Analyst Ratings February 12, 2026

Stifel Lifts Equinix Price Target to $1,075 After Strong 2026 Outlook

Analyst keeps Buy rating as guidance and bookings point to accelerating demand and improved AFFO growth

By Sofia Navarro EQIX
Stifel Lifts Equinix Price Target to $1,075 After Strong 2026 Outlook
EQIX

Stifel raised its price target for Equinix to $1,075 from $1,020 while retaining a Buy rating, citing 2026 guidance that exceeded expectations and showed a step-up in AFFO per share growth. The data center REIT reported record bookings and growth in recurring revenue despite fourth-quarter misses on earnings and revenue linked to a delayed large deal.

Key Points

  • Stifel raised its price target on Equinix to $1,075 from $1,020 and kept a Buy rating, reflecting upside from the current share price around $968.91.
  • Equinix posted record bookings of $474 million (up 42% year-over-year) and 10% growth in monthly recurring revenue despite Q4 earnings and revenue misses tied to a delayed large deal.
  • 2026 guidance topped expectations: revenue growth of 9%-10%, EBITDA margins of 51%, and AFFO per share growth of 8%-10% (vs prior outlook of roughly 5%+), supporting expectations for improved operating leverage and demand acceleration.

Stifel has increased its target price for Equinix (EQIX) to $1,075.00 from $1,020.00 and maintained a Buy recommendation on the company’s shares. The new target implies upside relative to the stock's trading level of $968.91 and comes as Equinix sits near its 52-week high.

Equinix’s most recent quarter contained a mix of headwinds and upside indicators. Reported fourth-quarter results fell short of expectations after a sizable contract was postponed into the first quarter of 2026. Despite that timing issue, the company recorded record bookings of $474 million - a 42% increase year-over-year - and posted a 10% year-over-year gain in monthly recurring revenue. Over the trailing twelve months, Equinix remained profitable with $1.07 billion in net income.

The company also reported operational milestones that underscore ongoing demand dynamics. Interconnections passed the 500,000 mark, stabilized-assets revenue rose 6% year-over-year, and the board approved a 10% increase to the quarterly dividend, marking the ninth straight year of dividend growth and producing a current yield of 2.16%.

Management set 2026 guidance that came in above analyst expectations. Revenue guidance targets 9% to 10% year-over-year growth, with projected EBITDA margins of 51%. Equinix signaled AFFO per share growth in the range of 8% to 10% for 2026 - a notable escalation from its prior outlook of roughly 5%+ growth. Stifel highlighted this raise in AFFO guidance as a meaningful step-up in the company’s earnings trajectory.

These forecasts align with the company’s historical top-line performance: Equinix has delivered a five-year revenue compound annual growth rate of 11%. Stifel also pointed to improving conversion metrics and pipeline dynamics to support the company’s momentum. In the fourth quarter, the conversion rate of the sales pipeline was 49%, and the firm expects faster sales cycles to translate into stronger conversions and bookings over the course of the year.

From a balance-sheet and liquidity perspective, Equinix is presented as operating with a moderate level of leverage and healthy near-term liquidity, including a current ratio of 1.34. The company’s market capitalization is reported at $94.5 billion, reflecting its scale within the Specialized REITs sector.

Despite the positive directional signals in guidance and backlog, the most recent quarter did include missed consensus figures. Fourth-quarter earnings per share were $2.69 versus a forecast of $3.71, and revenue for the quarter came in at $2.42 billion against a $2.46 billion expectation. Nevertheless, management’s outlook for the first quarter of 2026 and for the full year surpassed analyst estimates: full-year 2026 revenue was projected in a range of $10.12 billion to $10.22 billion, above the analyst consensus of $10.07 billion, and the company forecasted a 10.5% rise in adjusted funds from operations per share for 2026.

Other broker responses to Equinix’s results and outlook included a variety of upward target adjustments. TD Cowen raised its target to $1,123 and kept a Buy view, Scotiabank lifted its target to $997 citing strong backlog and site openings, and Citizens reiterated a Market Outperform rating with a $1,200 price objective. These actions reflect analyst recognition of both the underlying demand environment and the potential for earnings acceleration tied to the company’s guidance.


Takeaway - Equinix reported mixed quarter-to-quarter results but provided guidance for 2026 that improves the company’s near-term earnings growth outlook. Record bookings, higher recurring revenue, rising interconnections and a raised dividend contribute to a constructive operational picture, while the revenue and EPS misses in the fourth quarter underscore timing sensitivity tied to large deals.

Risks

  • Timing risk from large deals - a major contract was pushed into Q1 2026, demonstrating how deal timing can cause quarterly earnings and revenue volatility; this impacts investor returns and near-term REIT performance.
  • Execution and conversion uncertainty - while conversion rates improved to 49% in Q4, future execution on the sales pipeline and the speed of site openings will affect bookings and revenue realization for the data center sector.
  • Sensitivity to analyst expectations - recent quarterly EPS and revenue misses show that forecasts remain a risk factor for market reaction even when longer-term guidance is raised; this affects equity valuations within Specialized REITs and communications infrastructure stocks.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026